gip glp 1 glucagon agonists New strategies for the treatment of obesity and metabolic dysfunctions GLP-1 & GIP Agonists |

Experts warn that misuse of Ozempic and Mounjaro could trigger serious health risks without medical supervision.

Read how the new Wegovy pill compares to shots like Ozempic to learn which form might be best for you.

Todays DietitianVol

While fasting GLP-1 remained largely unchanged, postprandial concentrations rose markedly at 6 months (total AUC increase in RYGB: ~330%, OAGB: ~259%

Get the details.

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.